Showing results (341-350 of 8,446) with videos related to
Sort By:
Pageof 845
Journal of Neuroimmunology|April 12, 2025
Nitric oxide and experimental autoimmune encephalomyelitis reviewMaria Staykova, Anne BruestleJournal of Neuroimmunology|April 6, 2025
Glial changes in the dentate gyrus of neuronal-specific PTEN knockout mice correlate with changes in cell proliferationSarah E Latchney, Anjali C Raheja, Brayan R Ruiz Lopez, et al.Journal of Neuroimmunology|April 17, 2025
Retinal layer thinning as a predictor of demyelinating diseases of the central nervous system: Insights from a decade-long cohort studyJiatong Li, Zexu Chen, Liu Yang, et al.Journal of Neuroimmunology|April 1, 2025
Therapeutic potential of Baicalin against experimental obsessive compulsive disorder: Evidence from CSF, blood plasma, and brain analysisAbhinay Dhiman, Divya Choudhary, Sidharth Mehan, et al.Journal of Neuroimmunology|March 28, 2025
Ofatumumab for the treatment of COVID-19-associated autoimmune encephalitis: A case reportZhuoran Wang, Xiaoping Du, Qiong Wang, et al.Journal of Neuroimmunology|May 30, 2025
Inflammatory cerebral pseudotumour as a rare manifestation of neuro-Behçet's disease: A case report and literature reviewÓscar Porto Fuentes, Laura Lacruz Ballester, Jorge Álvarez Troncoso, et al.Journal of Neuroimmunology|June 6, 2025
Tumefactive demyelination as the first presentation of MOG ab-associated diseaseLin-Jie Zhang, Yuan Qi, Cui-Yun Sun, et al.Journal of Neuroimmunology|May 22, 2025
Anti-IL-6R antibody treatment changes microglial phenotype in AQP4 peptide-immunized mice, leading to suppression of myelitis severityShota Miyake, Yoshichika Katsura, Masayuki Baba, et al.Journal of Neuroimmunology|May 13, 2025
Anti-IL-6 receptor antibody suppresses onset of paralytic symptoms in AQP4 peptide-immunized mice without lowering bone strength or mineral densityHaruna Tomizawa-Shinohara, Yoshihiro Matsumoto, Shota Miyake, et al.Journal of Neuroimmunology|August 21, 2025
Immunostimulatory and immunomodulatory effects of duloxetine and venlafaxine on p38 MAPK and PI3K pathwaysEsra Aydemir, Derya Yetkin, Furkan AyazPageof 845